Tumor-Induced Osteomalacia (TIO)

Sponsored diagnostic testing programs for Tumor-Induced Osteomalacia (TIO)

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic disorder in which typically small, slow-growing tumors overproduce FGF23, causing renal phosphate wasting and impaired vitamin D metabolism. This results in bone pain, fractures, muscle weakness, and progressive osteomalacia. Symptoms often persist until the tumor is identified and removed.

1 program found for Tumor-Induced Osteomalacia (TIO)

Programs

1 program
X-linked Hypophosphatemia (XLH)Tumor-Induced Osteomalacia (TIO)

Hypophosphatemia

Sponsored by
Kyowa Kirin Inc.

Kyowa Kirin Sponsored Hypophosphatemia 13 Gene Panel

This program offers no-charge genetic testing and counseling for patients in the US and Canada who may have XLH or TIO and meet age and eligibility criteria. It aims to improve diagnostic accuracy, reduce time to confirmation, and support payer coverage needs. No patients, providers, or payers are billed, and program use does not require recommending or prescribing any Kyowa Kirin therapy.

Endocrinology
ViewOrder
Performing labInvitae | Labcorp